Quantum BioPharma Ltd.
QNTM
$3.24
-$0.20-5.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.66% | 1.80% | |||
| Depreciation & Amortization | 0.78% | -1.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.68% | 24.98% | |||
| Operating Income | 22.68% | -24.98% | |||
| Income Before Tax | 77.51% | -271.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 77.51% | -271.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -182.77% | -71.43% | |||
| Net Income | 76.01% | -348.05% | |||
| EBIT | 22.68% | -24.98% | |||
| EBITDA | 23.73% | -26.51% | |||
| EPS Basic | 83.81% | -282.44% | |||
| Normalized Basic EPS | 80.73% | -115.87% | |||
| EPS Diluted | 83.81% | -282.44% | |||
| Normalized Diluted EPS | 80.73% | -115.87% | |||
| Average Basic Shares Outstanding | 48.15% | 17.16% | |||
| Average Diluted Shares Outstanding | 48.15% | 17.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||